1. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers
Tsering Dhondup, Wonngarm Kittanamongkolchai, Lisa E. Vaughan, Ramila A. Mehta, Jasdeep K. Chhina, Felicity T. Enders, LaTonya J. Hickson, John C. Lieske, Andrew D. Rule 
American Journal of Kidney Diseases 
Volume 72, Issue 6, Pages (December 2018)
DOI: /j.ajkd
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

2. American Journal of Kidney Diseases 2018 72, 790-797DOI: (10. 1053/j
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

3. Figure 1
Stone former and non–stone former cohorts studied (sample size). Abbreviation: ESRD, end-stage renal disease.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

4. Figure 2
Unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for risk for end-stage renal disease by stone-former category. Adjusted for chronic kidney disease, hypertension, diabetes mellitus, dyslipidemia, obesity, and gout.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

5. Figure 3
Unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause mortality by stone-former category. Adjusted for chronic kidney disease, hypertension, diabetes mellitus, dyslipidemia, obesity, and gout.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions

6. Figure 4
Unadjusted and adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer mortality by stone-former category. Adjusted for chronic kidney disease, hypertension, diabetes mellitus, dyslipidemia, obesity, and gout.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2018 National Kidney Foundation, Inc. Terms and Conditions